Some scientists claim that peptides may become the drug of the future. Numerous studies demonstrate cell recovering qualities of peptides that affect the overall health of animals and humans. So what is the science behind peptides?

What is a peptide bioregulator?

Most people consider peptides as a smaller version of the protein. Although peptides and proteins have the same “origin” – the amino acids – they differ in their performance. Peptides are an ultra-short chain of amino acids, containing only 2-4. While proteins consist of a chain of more than 50 amino acids.

Short peptides were developed in the 70s of the last century by Prof. Khsavinson in the Military Medical Academy of the USSR. Groups of scientists discovered the ability of peptides to increase a cell’s life span and stimulate protein biosynthesis. They found out that peptides are able to restore the structure of the damaged cells and tissues.

A large number of clinical and scientific studies were handled since then showing the effectiveness of peptides with no side effects. The development of peptides is considered one of the major achievements in the field of rejuvenation over the past fifty years.

How do peptides work?

When a peptide reaches a cell it absorbs directly into its nucleus finally reaching its DNA. Peptides then help DNA to deliver better signal to proteins. Peptides have the following impact on the body:

  •  better protein regeneration and biosynthesis;
  •  activating body rejuvenation processes;
  •  increasing life resources;
  •  activating immunity;
  •  recovering all organs and systems in the body
  •  restoring glands and their healthy functioning.

Each organ and tissue has its own type of peptide and peptide don’t interact with each other.

The latest research on peptides

Various researches were carried out proving the effective performance of peptide bioregulators. Particularly the research on pineal gland peptides having active component Epithalamin.  15 years’ studies had reliable results of extending the life span of participants.

Other results were as follows:

  •  increased function of T-lymphocytes by 43%
  •  improved overall antioxidant status by 53%
  •  increased level of melatonin x2.4
  •  increased level of heterochromin by 42%
  •  telomere lengthening by 16%
  •  cardiovascular mortality reduction x2.1
  •  respiratory disease reduction х1.9
  •  improving short-term memory by 54%

Studies of ovarian peptide on female patients with menopausal syndrome of mild to moderate severity contributed to an improvement in general, condition which was manifested in a decrease in the number of hot flashes, improved sleep, appetite, and increased performance. 67% of participants had normalization of the menstrual cycle.

Studies on cardiovascular peptides on patients with arteriosclerosis, senile purpura and heart disease showed a decrease of pain symptoms, significant decrease in the frequency and duration of angina attacks. Also, the use of vascular peptides contributed to a significant decrease in the level of total cholesterol in the blood.

Thus, the results of the study indicate the therapeutic efficacy of peptide bioregulators and the feasibility of its use in the complex treatment of different pathologies.